Your browser is no longer supported. Please, upgrade your browser.
Settings
ENDP Endo International plc daily Stock Chart
ENDP [NASD]
Endo International plc
IndexS&P 500 P/E- EPS (ttm)-0.98 Insider Own0.50% Shs Outstand204.60M Perf Week-1.30%
Market Cap17.56B Forward P/E16.42 EPS next Y5.23 Insider Trans0.00% Shs Float200.92M Perf Month4.37%
Income-134.20M PEG- EPS next Q1.02 Inst Own90.40% Short Float4.52% Perf Quarter-5.33%
Sales3.00B P/S5.86 EPS this Y-4.70% Inst Trans0.07% Short Ratio3.90 Perf Half Y8.41%
Book/sh24.40 P/B3.52 EPS next Y15.29% ROA-3.20% Target Price101.93 Perf Year25.22%
Cash/sh1.85 P/C46.37 EPS next 5Y12.50% ROE-12.20% 52W Range57.14 - 96.58 Perf YTD18.98%
Dividend- P/FCF42.50 EPS past 5Y-33.10% ROI-7.70% 52W High-11.15% Beta1.28
Dividend %- Quick Ratio1.40 Sales past 5Y14.50% Gross Margin48.80% 52W Low50.18% ATR1.78
Employees5062 Current Ratio1.50 Sales Q/Q51.70% Oper. Margin19.40% RSI (14)57.70 Volatility1.85% 2.26%
OptionableYes Debt/Eq1.34 EPS Q/Q322.50% Profit Margin-12.00% Rel Volume0.59 Prev Close85.81
ShortableYes LT Debt/Eq1.30 EarningsJul 30 BMO Payout- Avg Volume2.33M Price85.81
Recom1.90 SMA202.93% SMA503.10% SMA2007.12% Volume0 Change0.00%
Jul-17-15Upgrade RBC Capital Mkts Outperform → Top Pick $98 → $107
Jun-15-15Reiterated Stifel Buy $95 → $115
Jun-03-15Initiated Raymond James Mkt Perform
May-29-15Reiterated Guggenheim Buy $100 → $110
May-22-15Reiterated Cantor Fitzgerald Hold $80 → $92
Apr-16-15Reiterated Piper Jaffray Overweight $102 → $110
Apr-13-15Reiterated Deutsche Bank Buy $91 → $96
Mar-03-15Reiterated RBC Capital Mkts Outperform $80 → $98
Feb-02-15Reiterated CRT Capital Fair Value $73 → $80
Jan-30-15Reiterated Deutsche Bank Buy $81 → $91
Sep-02-14Initiated RBC Capital Mkts Outperform $80
Aug-01-14Reiterated Stifel Buy $75 → $84
Jun-27-14Initiated Canaccord Genuity Buy $83
Apr-30-14Initiated National Alliance Securities Buy $76
Mar-04-14Reiterated FBR Capital Mkt Perform $52 → $82
Mar-03-14Reiterated UBS Buy $75 → $90
Nov-06-13Upgrade Needham Underperform → Hold
Nov-06-13Reiterated Stifel Buy $40 → $60
Oct-30-13Initiated FBR Capital Mkt Perform $40
Sep-20-13Reiterated UBS Buy $43 → $50
Jul-27-15 08:00AM  Endo to Announce Second Quarter 2015 Financial Results on August 10, 2015 PR Newswire
08:00AM  Endo to Announce Second Quarter 2015 Financial Results on August 10, 2015 CNW Group
Jul-23-15 02:57PM  Mylan's Stichting: Will It Work? at Barrons.com
02:04PM  Why Carl Icahn Warned about the High Yield Bond Market Bubble
11:11AM  Valeant Pharmaceuticals: All That Deal Making Pays Off? at Barrons.com
Jul-17-15 09:36AM  Up with Endo, Down with AllerganSort Of at Barrons.com
08:02AM  Painkiller Abuse Drives Drugmakers To Innovate at Investor's Business Daily
06:14AM  Endo Health upgraded by RBC Capital Mkts
Jul-16-15 04:56PM  Heres Why This Hedge Fund Manager Sold Out Of Apple Inc (AAPL), Amazon.com Inc (AMZN), And Netflix Inc (NFLX) at Insider Monkey
03:59PM  Tenet Healthcare Headlined June in Junk Bond Issuance
Jul-14-15 01:06PM  Billionaire George Soros Latest Move Involves Cypress Semiconductor Corporation (CY); His Holdings Return -2.2% in Q2 at Insider Monkey
Jul-09-15 04:34PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial
Jul-02-15 01:06PM  Leveraged Loans Issuance Volume Picks Up in the Week of June 26
01:06PM  High Yield Bond Funds Witness Inflows in the Week of June 26
12:43PM  Billionaires George Soros and James Dinan Love These Stocks at Insider Monkey
Jul-01-15 03:46PM  Endo International: Biggest Junk Bond Issuer in Week of June 26
03:45PM  High Yield Bond Issuances Rise in the Week Ending June 26
01:13PM  Top Takeaways From BMO's Specialty Pharma Day
11:50AM  Egalet Reports Encouraging Results on Pain Drug Egalet-002 - Analyst Blog
12:38AM  Behind the Foreign Shopping Spree for U.S. Companies at The Wall Street Journal
Jun-30-15 06:57PM  Behind the Foreign Shopping Spree for U.S. Companies at The Wall Street Journal
Jun-25-15 04:07PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Entry into a Material Definitive Agreement
Jun-24-15 04:30PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:01PM  Endo International plc Announces Conditional Redemption of All $499,875,000 Aggregate Principal Amount Outstanding of the Two Series of 7.00% Senior Notes due 2019 PR Newswire
04:01PM  Endo International plc Announces Conditional Redemption of All $499,875,000 Aggregate Principal Amount Outstanding of the Two Series of 7.00% Senior Notes due 2019 CNW Group
01:19PM  Endo International plc Announces Pricing of Private Offering Of Senior Notes PR Newswire
01:19PM  Endo International plc Announces Pricing of Private Offering Of Senior Notes CNW Group
Jun-19-15 09:10AM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:00AM  Endo International plc Announces Proposed Private Offering Of Senior Notes PR Newswire
09:00AM  Endo International plc Announces Proposed Private Offering Of Senior Notes CNW Group
Jun-16-15 09:08AM  Buy These 6 Risky Pharmaceutical Stocks for Big Upside Potential at TheStreet
Jun-15-15 04:40PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhib
Jun-11-15 12:20AM  Dodge & Cox Buys 2 New Stocks
Jun-10-15 06:32PM  Endo Finance LLC -- Moody's Confirms Endo's CFR at Ba3; outlook negative at Moody's
04:16PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:01PM  Endo International plc Closes Offering of 27,627,628 Ordinary Shares PR Newswire
04:01PM  Endo International plc Closes Offering of 27,627,628 Ordinary Shares CNW Group
07:35AM  ARIAD and Paladin Announce Commercial Distribution Agreement for Iclusig (Ponatinib) in Canada Business Wire
Jun-09-15 04:48PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Financial Statements
Jun-05-15 04:14PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
10:01AM  M&A boom: It's different this time Reuters
Jun-04-15 11:57PM  Endo International plc Prices Offering of 24,024,025 Ordinary Shares PR Newswire
11:57PM  Endo International plc Prices Offering of 24,024,025 Ordinary Shares CNW Group
Jun-03-15 11:22AM  The Morning Leverage: Synchronoss Exploring a Sale at The Wall Street Journal
Jun-02-15 06:27PM  Endo Plans Stock Sale to Fund Par Deal at The Wall Street Journal
05:35PM  Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares PR Newswire
05:35PM  Endo International plc Announces Proposed Public Offering of $1.75 Billion of Ordinary Shares CNW Group
05:33PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Other Events
11:13AM  Activist Keith Meisters New Additions to His Funds Portfolio Include Yum! Brands, Inc. (YUM), MGM Resorts International (MGM) at Insider Monkey
May-27-15 04:10PM  Tailwinds for US Equities Today
May-22-15 12:17PM  Will This Analyst Action Affect Endo Int'l. (ENDP) Stock? at TheStreet
May-21-15 06:05AM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Se
May-20-15 08:00AM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
May-19-15 02:16PM  7 Biotech Stocks Moving Off The UBS Healthcare Conference
11:01AM  Pharma buying spree continues
10:10AM  Company News for May 19, 2015 - Corporate Summary
10:05AM  Fed afraid of everything: LaVorgna
09:34AM  Jim Cramer -- Stock Market's Takeover Frenzy Won't End Anytime Soon at TheStreet
09:30AM  DKS has a golf problem: Cramer
09:14AM  Story Stocks from Briefing.com Briefing.com
07:30AM  First Ever Peyronie's Disease (PD) Treatment Guidelines Support Use of XIAFLEX┬« in Appropriate Patients PR Newswire
07:30AM  First Ever Peyronie's Disease (PD) Treatment Guidelines Support Use of XIAFLEX┬« in Appropriate Patients CNW Group
12:41AM  Overheard: For Bankers, a Means to an Endo at The Wall Street Journal
12:38AM  [$$] Endo to Buy Par Pharma for About $8 Billion at The Wall Street Journal
12:18AM  PRESS DIGEST- New York Times business news - May 19 Reuters
May-18-15 08:31PM  PRESS DIGEST- Financial Times - May 19 Reuters -5.37%
08:03PM  Drug Deal to Generate Tax Benefits at The Wall Street Journal
06:56PM  Ann and Endo big market movers
05:45PM  Stock Pops & Drops: WB, ENDP, SWKS & GMCR
05:22PM  For Bankers, a Means to an Endo -- Overheard at The Wall Street Journal
04:57PM  Endo International (ENDP) Expands Generics with $8 Billion Par Pharma Buy - Stocks in the News
04:54PM  Endo Vaults Into Top 5 Among Generic-Drug Firms
04:54PM  Endo Buying Par Pharma To Become Top Generics Player at Investor's Business Daily
04:30PM  Stocks End Higher; S&P 500, Dow Hit New Record Highs
04:15PM  Drug Takeover Valuations Soar as Par Pharma Gains 300%: Real M&A at Bloomberg
04:05PM  Endo Buys Par Pharma for $8.05 Billion Amid Hunt for Deals
03:54PM  For Bankers, a Means to an Endo at The Wall Street Journal
03:05PM  Endo Finance Co. -- Moody's reviews Endo's ratings for downgrade at Moody's
02:49PM  Endo buying Par for $8B in push for generics, higher profit
02:32PM  Endo buying Par for $8 billion in a big generics push at Los Angeles Times
02:15PM  US STOCKS-Dow, S&P hit record highs as rate-hike worries fade
01:50PM  S&P 500, Dow Hit Intraday Records as Apple Grinds Higher at TheStreet
01:33PM  Inside the Endo Deal to Buy Par Pharma for $8.05B at Bloomberg
01:04PM  US STOCKS-Dow, S&P touch record highs
12:57PM  Endo buying Par for $8 billion in a big generics push
12:02PM  Endo Buys Par Pharmaceutical for $8.05B to Expand in U.S. Generics at TheStreet
12:00PM  Stocks Modestly Higher
11:41AM  Endo buys Par Pharma for $8B to expand generics at USA TODAY
11:17AM  [video]Stocks Trade Flat; Icahn Says Apple Remains 'Undervalued' at TheStreet
10:59AM  US STOCKS-Wall St down as homebuilder confidence slips
10:35AM  Endo International: Is Par a Good Fit? at Barrons.com
10:10AM  Endo Int'l. (ENDP) Stock Declines After $8 Billion Purchase of Par Pharmaceutical at TheStreet
09:50AM  US STOCKS-Wall St opens mixed ahead of homebuilder sentiment data
09:14AM  Endo buying generic drug maker for $8B at bizjournals.com
09:11AM  Stock Futures Step Back as Oil Prices Climb at TheStreet
09:04AM  ANN soars on Ascena buyout; Altera, Intel talks back on?; Endo buys Par
08:33AM  The pharma M&A party is still in full swing, as Endo snaps up Par at Fortune
08:14AM  Investors' hangover; Target's health food kick; AMC's new dawn
08:08AM  Endo buying Par in $8.05 billion cash-and-stock deal
08:02AM  Endo buys Par from TPG for $8.05 billion
Endo International plc, a specialty healthcare company, focuses on branded and generic pharmaceuticals and devices worldwide. It operates through four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices, and International Pharmaceuticals. The U.S. Branded Pharmaceuticals segment provides various branded prescription products, including Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Fortesta Gel, Supprelin LA, Valstar, Vantas, Sumavel DosePro, Aveed, and Natesto to treat and manage pain and conditions in urology, endocrinology, and oncology. The U.S. Generic Pharmaceuticals segment offers products in the pain management, urology, CNS disorders, immunosuppression, oncology, women's health, hypertension, generic lidocaine patch, and other markets. The Devices segment provides various medical devices comprising AMS 800 artificial urinary sphincters, AMS 700 MS series, Monarc subfascial hammock products, Elevate anterior and posterior pelvic floor repair systems, and GreenLight XPS laser systems in the areas of men's and women's pelvic health. The International Pharmaceuticals segment offers Dexedrine, Tridural, Metadol, Trandate, Pennsaid, and Plan B products in therapeutic areas, including attention deficit hyperactivity disorder, pain, urology, and allergy. It sells its branded pharmaceuticals and generics directly to large pharmacy chains; and through wholesale drug distributors to pharmacies, hospitals, governmental agencies, and physicians. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.